Nutritional Aspects in Inflammatory Bowel Diseases

Overview

Journal Nutrients

Date 2020 Feb 7

PMID 32023881

Citations 94

Authors

Paola Balestrieri

Mentore Ribolsi

Michele Pier Luca Guarino

Sara Emerenziani

Annamaria Altomare

Michele Cicala

Affiliations

Soon will be listed here.

Abstract

Crohn's disease (CD) and ulcerative colitis (UC) are chronic, relapsing, inflammatory disorders of the digestive tract that characteristically develop in adolescence and early adulthood. The reported prevalence of malnutrition in inflammatory bowel disease (IBD) patients ranges between 20% and 85%. Several factors, including reduced oral food intake, malabsorption, chronic blood and proteins loss, and intestinal bacterial overgrowth, contribute to malnutrition in IBD patients. Poor nutritional status, as well as selective malnutrition or sarcopenia, is associated with poor clinical outcomes, response to therapy and, therefore, quality of life. The nutritional assessment should include a dietetic evaluation with the assessment of daily caloric intake and energy expenditure, radiological assessment, and measurement of functional capacity.

Citing Articles

Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran.

Karami H, Ghanbarnejad A, Nowrouzpour M, Mouseli A, Taheri Kondar R, Shirvani Shiri M BMC Health Serv Res. 2025; 25(1):341.

PMID: 40045278 PMC: 11884057. DOI: 10.1186/s12913-025-12474-6.

Bifidobacterium animalis subsp. lactis A6 ameliorates bone and muscle loss via modulating gut microbiota composition and enhancing butyrate production.

Chen M, Li Y, Zhai Z, Wang H, Lin Y, Chang F Bone Res. 2025; 13(1):28.

PMID: 40000617 PMC: 11862215. DOI: 10.1038/s41413-024-00381-1.

Possible Use of Body Surface Area Value for Estimating Skeletal Muscle Mass in Chronic Liver Disease.

Yoh K, Nishimura T, Ikeda N, Takashima T, Aizawa N, Yuri Y Diagnostics (Basel). 2025; 15(3).

PMID: 39941193 PMC: 11817660. DOI: 10.3390/diagnostics15030263.

Is There Any Association Between Fat Body Mass and Bone Mineral Density in Patients with Crohn's Disease and Ulcerative Colitis?.

Ratajczak-Pawlowska A, Michalak M, Szymczak-Tomczak A, Rychter A, Zawada A, Skoracka K Nutrients. 2025; 17(3).

PMID: 39940324 PMC: 11820439. DOI: 10.3390/nu17030466.

Reactions, Reality, and Resilience in Adults with Crohn's Disease: A Qualitative Study.

Jones K, Baker K, Tew G, Naisby J Crohns Colitis 360. 2025; 7(1):otaf003.

PMID: 39917030 PMC: 11799741. DOI: 10.1093/crocol/otaf003.

References

Jansen I, Prager M, Valentini L, Buning C . Inflammation-driven malnutrition: a new screening tool predicts outcome in Crohn's disease. Br J Nutr. 2016; 116(6):1061-7. DOI: 10.1017/S0007114516003044. View

Heuschkel R, Menache C, Megerian J, Baird A . Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 2000; 31(1):8-15. DOI: 10.1097/00005176-200007000-00005. View

Barbat-Artigas S, Rolland Y, Zamboni M, Aubertin-Leheudre M . How to assess functional status: a new muscle quality index. J Nutr Health Aging. 2012; 16(1):67-77. DOI: 10.1007/s12603-012-0004-5. View

Bermejo F, Algaba A, Guerra I, Chaparro M, De-La-Poza G, Valer P . Should we monitor vitamin B12 and folate levels in Crohn's disease patients?. Scand J Gastroenterol. 2013; 48(11):1272-7. DOI: 10.3109/00365521.2013.836752. View

Cantorna M, Zhu Y, Froicu M, Wittke A . Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004; 80(6 Suppl):1717S-20S. DOI: 10.1093/ajcn/80.6.1717S. View

Griffiths A, Ohlsson A, Sherman P, Sutherland L . Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995; 108(4):1056-67. DOI: 10.1016/0016-5085(95)90203-1. View

Zachos M, Tondeur M, Griffiths A . Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007; (1):CD000542. DOI: 10.1002/14651858.CD000542.pub2. View

Brotherton C, Martin C, Long M, Kappelman M, Sandler R . Avoidance of Fiber Is Associated With Greater Risk of Crohn's Disease Flare in a 6-Month Period. Clin Gastroenterol Hepatol. 2016; 14(8):1130-6. PMC: 4930425. DOI: 10.1016/j.cgh.2015.12.029. View

Bryant R, Ooi S, Schultz C, Goess C, Grafton R, Hughes J . Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015; 41(9):895-906. DOI: 10.1111/apt.13156. View

10.

Goodpaster B, Park S, Harris T, Kritchevsky S, Nevitt M, Schwartz A . The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006; 61(10):1059-64. DOI: 10.1093/gerona/61.10.1059. View

11.

Gasche C . Anemia in IBD: the overlooked villain. Inflamm Bowel Dis. 2000; 6(2):142-150; discussion 151. DOI: 10.1097/00054725-200005000-00013. View

12.

Prince A, Myers C, Joyce T, Irving P, Lomer M, Whelan K . Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016; 22(5):1129-36. DOI: 10.1097/MIB.0000000000000708. View

13.

Bannerjee K, Camacho-Hubner C, Babinska K, Dryhurst K, Edwards R, Savage M . Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr. 2004; 38(3):270-5. DOI: 10.1097/00005176-200403000-00007. View

14.

Talbot R, Heppell J, Dozois R, Beart Jr R . Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986; 61(2):140-5. DOI: 10.1016/s0025-6196(12)65200-8. View

15.

Dignass A, Gasche C, Bettenworth D, Birgegard G, Danese S, Gisbert J . European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2014; 9(3):211-22. DOI: 10.1093/ecco-jcc/jju009. View

16.

Donnellan C, Yann L, Lal S . Nutritional management of Crohn's disease. Therap Adv Gastroenterol. 2013; 6(3):231-42. PMC: 3625021. DOI: 10.1177/1756283X13477715. View

17.

Bone A, Hepgul N, Kon S, Maddocks M . Sarcopenia and frailty in chronic respiratory disease. Chron Respir Dis. 2016; 14(1):85-99. PMC: 5720213. DOI: 10.1177/1479972316679664. View

18.

Goh J, OMorain C . Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther. 2003; 17(3):307-20. DOI: 10.1046/j.1365-2036.2003.01482.x. View

19.

Forbes A, Escher J, Hebuterne X, Klek S, Krznaric Z, Schneider S . ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017; 36(2):321-347. DOI: 10.1016/j.clnu.2016.12.027. View

20.

Guagnozzi D, Gonzalez-Castillo S, Olveira A, Lucendo A . Nutritional treatment in inflammatory bowel disease. An update. Rev Esp Enferm Dig. 2012; 104(9):479-88. DOI: 10.4321/s1130-01082012000900006. View